(Q39254723)
Statements
1 reference
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blocker (English)
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker (English)
W. Frishman
R. Silverman
J. Strom
U. Elkayam
1 August 1979
1 reference
1 reference
19
203
the clinical pharmacology of beta-adrenoceptor-blocking drugs (English)
Conolly
1976
7
226
Cardiospecificity of beta-receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular beta-adrenoceptors of propranolol, of practolol and its ortho-substituted isomer (English)
Vaughan-Williams
1973
10
292
Perspectives in adrenergic beta-receptor blockade (English)
Fitzgerald
1969
31
216
β-adrenergic blockade and atrio-ventricular conduction impairment (English)
Giudicelli
1975
81
925
Coronary artery syndromes after sudden propranolol withdrawal (English)
Alderman
1974
293
416
Propranolol withdrawal rebound phenomenon: exacerbation of coronary events after abrupt cessation of anti-anginal therapy (English)
Miller
1975
95
169
Abrupt propranolol withdrawal in angina pectoris: Effects on platelet aggregation and exercise tolerance (English)
Frishman
1978
32
201
Selective blockade of adrenoceptive beta receptors in the heart (English)
Dunlop
1968
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference